Mini review: The FDA-approved prescription drugs that induce ovulation in women with ovulatory problems

被引:5
|
作者
Sun, Chunlei [1 ]
Rong, Xi [2 ]
Cai, Yongqin [3 ]
Qiu, Song [4 ]
Farzaneh, Maryam [5 ]
机构
[1] Yidu Cent Hosp Weifang, Dept Pediat, Weifang, Peoples R China
[2] Yidu Cent Hosp Weifang, Dept Pharm, Weifang, Peoples R China
[3] Yidu Cent Hosp Weifang, Dept Gynaecol, Weifang, Peoples R China
[4] Weifang Peoples Hosp, Imaging Dept Brain Hosp, Weifang 261021, Peoples R China
[5] Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Ahvaz, Iran
关键词
FDA-approved drugs; in vitro fertilization; infertility; ovulation; polycystic ovary syndrome; FOLLICLE-STIMULATING-HORMONE; POLYCYSTIC-OVARY-SYNDROME; CLOMIPHENE CITRATE; CORIFOLLITROPIN ALPHA; BROMOCRIPTINE TREATMENT; FEMALE INFERTILITY; PREGNANCY RATE; LETROZOLE; GONADOTROPINS; METFORMIN;
D O I
10.1002/ddr.21687
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Infertility is defined as not being able to become pregnant after 12 months or more of unprotected sexual intercourse. Female infertility as a serious health issue can result from ovulation disorders, menstrual cycle problems, structural problems, and environmental factors. Ovulation occurs once a month between the time of menarche and menopause. The release of a mature egg from the ovary is controlled with the hypothalamic-pituitary-ovarian axis. Several hormones such as gonadotropin-releasing hormone (GnRH), FSH (follicle-stimulating hormone), LH (luteinizing hormone), estrogen, and progesterone play fundamental roles in the ovulation process. Both FSH and LH are the main treatment for women with ovulation disorders. Depending on the reasons for infertility, several different types of treatment are available for infertile women. Fertility drugs as an important part of treatment work like the natural hormones to treat infertility. Several fertility drugs can regulate ovulation and the release of an egg from the ovary in women with polycystic ovary syndrome (PCOS) or undergoing in vitro fertilization (IVF) treatment. This mini-review is about the FDA-approved prescription drugs that induce ovulation in women with ovulatory problems.
引用
收藏
页码:815 / 822
页数:8
相关论文
共 50 条
  • [1] A review on synthesis of FDA-approved antipsychotic drugs
    Rani, Anjali
    Aslam, Mohd
    Pandey, Garima
    Pant, Bhaskara Nand
    TETRAHEDRON, 2023, 138
  • [2] Identification of FDA-approved drugs that induce heart regeneration in mammals
    Mahmoud Salama Ahmed
    Ngoc Uyen Nhi Nguyen
    Yuji Nakada
    Ching-Cheng Hsu
    Ayman Farag
    Nicholas T. Lam
    Ping Wang
    Suwannee Thet
    Ivan Menendez-Montes
    Waleed M. Elhelaly
    Xi Lou
    Ilaria Secco
    Mateusz Tomczyk
    Lorena Zentilin
    Jimin Pei
    Miao Cui
    Matthieu Dos Santos
    Xiaoye Liu
    Yan Liu
    David Zaha
    Gregory Walcott
    Diana R. Tomchick
    Chao Xing
    Cheng Cheng Zhang
    Nick V. Grishin
    Mauro Giacca
    Jianyi Zhang
    Hesham A. Sadek
    Nature Cardiovascular Research, 2024, 3 : 372 - 388
  • [3] Identification of FDA-Approved Drugs That Induce Heart Regeneration in Mammals
    Nguyen, Ngoc U.
    Ahmed, Mahmoud S.
    Nakada, Yuji
    Hsu, Ching-Cheng
    Farag, Ayman
    Wang, Ping
    Menendez-Montes, Ivan
    Thet, Suwannee
    Lam, Nicholas T.
    Tomchick, Diana R.
    Walcott, Gregory
    Grishin, Nick V.
    Zhang, Jianyi J.
    Sadek, Hesham A.
    CIRCULATION RESEARCH, 2022, 131 (12) : E171 - E171
  • [4] Identification of FDA-approved drugs that induce heart regeneration in mammals
    Ahmed, Mahmoud Salama
    Nguyen, Ngoc Uyen Nhi
    Nakada, Yuji
    Hsu, Ching-Cheng
    Farag, Ayman
    Lam, Nicholas T.
    Wang, Ping
    Thet, Suwannee
    Menendez-Montes, Ivan
    Elhelaly, Waleed M.
    Lou, Xi
    Secco, Ilaria
    Tomczyk, Mateusz
    Zentilin, Lorena
    Pei, Jimin
    Cui, Miao
    Dos Santos, Matthieu
    Liu, Xiaoye
    Liu, Yan
    Zaha, David
    Walcott, Gregory
    Tomchick, Diana R.
    Xing, Chao
    Zhang, Cheng Cheng
    Grishin, Nick V.
    Giacca, Mauro
    Zhang, Jianyi
    Sadek, Hesham A.
    NATURE CARDIOVASCULAR RESEARCH, 2024, 3 (3): : 372 - 388
  • [5] Prevalence and Therapeutic Classifications of FDA-Approved Prescription Drugs With Boxed Warnings
    Christine M. Cheng
    Colleen DeLizza
    Joan Kapusnik-Uner
    Therapeutic Innovation & Regulatory Science, 2014, 48 : 165 - 172
  • [6] Prevalence and Therapeutic Classifications of FDA-Approved Prescription Drugs With Boxed Warnings
    Cheng, Christine M.
    DeLizza, Colleen
    Kapusnik-Uner, Joan
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2014, 48 (02) : 165 - 172
  • [7] The guide to off-label prescription drugs: New uses for FDA-approved prescription drugs.
    Flahiff, J
    LIBRARY JOURNAL, 2006, 131 (07) : 112 - 112
  • [8] Safety of FDA-Approved drugs - Reply
    Friedman, MA
    Woodcock, J
    Lumpkin, MM
    Shuren, JE
    Hass, AE
    Thompson, LJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (24): : 2297 - 2298
  • [9] NONAPPROVED USES OF FDA-APPROVED DRUGS
    ANDERSON, BJ
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 211 (10): : 1705 - &
  • [10] An analysis of FDA-approved drugs for oncology
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2014, 19 (12) : 1831 - 1835